Arkansas Legal Resource Navigator

42 U.S.C. § 7671e — Accelerated schedule

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 7671e — Accelerated schedule

Page 7456 TITLE 42—THE PUBLIC HEALTH AND WELFARE § 7671e istrator shall also promulgate regulations to in- sure that the consumption of class II substances in the United States is phased out and termi- nated in accordance with the same schedule (subject to the same exceptions and other provi- sions) as is applicable to the phase-out and ter- mination of production of class II substances under this subchapter. (d) Exceptions (1) Medical devices (A) In general Notwithstanding the termination of pro- duction required under subsection (b)(2) and the restriction on use referred to in sub- section (a), the Administrator, after notice and opportunity for public comment, shall, to the extent such action is consistent with the Montreal Protocol, authorize the pro- duction and use of limited quantities of class II substances solely for purposes of use in medical devices if such authorization is de- termined by the Commissioner, in consulta- tion with the Administrator, to be necessary for use in medical devices. (B) Cap on exception Under no circumstances may the authority set forth in subparagraph (A) be applied to authorize any person to produce a class II substance in annual quantities greater than 10 percent of that produced by such person during the baseline year. (2) Developing countries (A) In general Notwithstanding the provisions of sub- section (a) or (b), the Administrator, after notice and opportunity for public comment, may authorize the production of limited quantities of a class II substance in excess of the quantities otherwise permitted under such provisions solely for export to and use in developing countries that are Parties to the Montreal Protocol, as determined by the Administrator. Any production authorized under this subse

Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 7671e

Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 0ef6309440af0c64aebec35c0241ec08bfc93f28a374ff471adb2aa917cc7fed. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:usc2024-b41a6737c4ad437f23a038dc
Source file: Laws/federal/codes/united-states-code-2024/title-42/section-7671e-accelerated-schedule--2a15f74a74.md
Pages: Not recorded – Not recorded
Passage SHA-256: 23f3934a9448144c6c659aead8db0ee69163971e8f067537bb346f121675a619

Source location: USCODE-2024-title42-chap85-subchapVI-sec7671e.pdf

Stored source content

Page 7456 TITLE 42—THE PUBLIC HEALTH AND WELFARE § 7671e istrator shall also promulgate regulations to in- sure that the consumption of class II substances in the United States is phased out and termi- nated in accordance with the same schedule (subject to the same exceptions and other provi- sions) as is applicable to the phase-out and ter- mination of production of class II substances under this subchapter. (d) Exceptions (1) Medical devices (A) In general Notwithstanding the termination of pro- duction required under subsection (b)(2) and the restriction on use referred to in sub- section (a), the Administrator, after notice and opportunity for public comment, shall, to the extent such action is consistent with the Montreal Protocol, authorize the pro- duction and use of limited quantities of class II substances solely for purposes of use in medical devices if such authorization is de- termined by the Commissioner, in consulta- tion with the Administrator, to be necessary for use in medical devices. (B) Cap on exception Under no circumstances may the authority set forth in subparagraph (A) be applied to authorize any person to produce a class II substance in annual quantities greater than 10 percent of that produced by such person during the baseline year. (2) Developing countries (A) In general Notwithstanding the provisions of sub- section (a) or (b), the Administrator, after notice and opportunity for public comment, may authorize the production of limited quantities of a class II substance in excess of the quantities otherwise permitted under such provisions solely for export to and use in developing countries that are Parties to the Montreal Protocol, as determined by the Administrator. Any production authorized under this subsection shall be solely for pur- poses of satisfying the basic domestic needs of such countries. (B) Cap on exception (i) Under no circumstances may the au- thority set forth in subparagraph (A) be ap- plied to authorize any person to produce a class II substance in any year following the effective date of subsection (b)(1) and before the year 2030 in annual quantities greater than 110 percent of the quantity of such sub- stance produced by such person during the baseline year. (ii) Under no circumstances may the au- thority set forth in subparagraph (A) be ap- plied to authorize any person to produce a class II substance in the year 2030, or any year thereafter, in an annual quantity great- er than 15 percent of the quantity of such substance produced by such person during the baseline year. (iii) Each exception authorized under this paragraph shall terminate no later than Jan- uary 1, 2040. (July 14, 1955, ch. 360, title VI, § 605, as added Pub. L. 101–549, title VI, § 602(a), Nov. 15, 1990, 104 Stat. 2658; amended Pub. L. 112–81, div. A, title III, § 320, Dec. 31, 2011, 125 Stat. 1361.) Editorial Notes AMENDMENTS 2011—Subsec. (a)(4). Pub. L. 112–81 added par. (4). § 7671e. Accelerated schedule (a) In general The Administrator shall promulgate regula- tions, after notice and opportunity for public comment, which establish a schedule for phasing out the production and consumption of class I and class II substances (or use of class II sub- stances) that is more stringent than set forth in section 7671c or 7671d of this title, or both, if— (1) based on an assessment of credible cur- rent scientific information (including any as- sessment under the Montreal Protocol) regard- ing harmful effects on the stratospheric ozone layer associated with a class I or class II sub- stance, the Administrator determines that such more stringent schedule may be nec- essary to protect human health and the envi- ronment against such effects, (2) based on the availability of substitutes for listed substances, the Administrator deter- mines that such more stringent schedule is practicable, taking into account technological achievability, safety, and other relevant fac- tors, or (3) the Montreal Protocol is modified to in- clude a schedule to control or reduce produc- tion, consumption, or use of any substance more rapidly than the applicable schedule under this subchapter. In making any determination under paragraphs (1) and (2), the Administrator shall consider the status of the period remaining under the appli- cable schedule under this subchapter. (b) Petition Any person may petition the Administrator to promulgate regulations under this section. The Administrator shall grant or deny the petition within 180 days after receipt of any such peti- tion. If the Administrator denies the petition, the Administrator shall publish an explanation of why the petition was denied. If the Adminis- trator grants such petition, such final regula- tions shall be promulgated within 1 year. Any petition under this subsection shall include a showing by the petitioner that there are data adequate to support the petition. If the Admin- istrator determines that information is not suf- ficient to make a determination under this sub- section, the Administrator shall use any author- ity available to the Administrator, under any law administered by the Administrator, to ac- quire such information. (July 14, 1955, ch. 360, title VI, § 606, as added Pub. L. 101–549, title VI, § 602(a), Nov. 15, 1990, 104 Stat. 2660.) § 7671f. Exchange authority (a) Transfers The Administrator shall, within 10 months after November 15, 1990, promulgate rules under

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 7671e — Accelerated schedule

**(a) In general** The Administrator shall promulgate regulations, after notice and opportunity for public comment, which establish a schedule for phasing out the production and consumption of class I and class II substances (or use of class II substances) that is more stringent than set forth in section 7671c or 7671d of this title, or both, if— (1) based on an assessment of credible current scientific information (including any assessment under the Montreal Protocol) regarding harmful effects on the stratospheric ozone layer associated with a class I or class II substance, the Administrator determines that such more stringent schedule may be necessary to protect human health and the environment against such effects, (2) based on the availability of substitutes for listed substances, the Administrator determines that such more stringent schedule is practicable, taking into account technological achievability, safety, and other relevant factors, or (3) the Montreal Protocol is modified to include a schedule to control or reduce production, consumption, or use of any substance more rapidly than the applicable schedule under this subchapter. In making any determination under paragraphs (1) and (2), the Administrator shall consider the status of the period remaining under the applicable schedule under this subchapter. **(b) Petition** Any person may petition the Administrator to promulgate regulations under this section. The Administrator shall grant or deny the petition within 180 days after receipt of any such petition. If the Administrator denies the petition, the Administrator shall publish an explanation of why the petition was denied. If the Administrator grants such petition, such final regulations shall be promulgated within 1 year. Any petition under this subs

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 7671e

Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.